$1.06 EPS Expected for STERIS plc (STE)

October 14, 2018 - By Marguerite Chambers

STERIS plc (NYSE:STE) LogoInvestors sentiment increased to 1 in Q2 2018. Its up 0.67, from 0.33 in 2018Q1. It is positive, as 1 investors sold STERIS plc shares while 1 reduced holdings. 2 funds opened positions while 0 raised stakes. 20,526 shares or 4.54% less from 21,503 shares in 2018Q1 were reported.
Moreover, Whittier Of Nevada has 0.01% invested in STERIS plc (NYSE:STE) for 900 shares. Alphamark Advsr Ltd Liability holds 0.01% in STERIS plc (NYSE:STE) or 150 shares. 13,176 are held by Fruth Mgmt. Penobscot Com has invested 0.06% in STERIS plc (NYSE:STE). Prudential Public Limited Company invested in 0% or 3,800 shares.

Analysts expect STERIS plc (NYSE:STE) to report $1.06 EPS on November, 7.They anticipate $0.12 EPS change or 12.77 % from last quarter’s $0.94 EPS. STE’s profit would be $89.70 million giving it 25.02 P/E if the $1.06 EPS is correct. After having $1.00 EPS previously, STERIS plc’s analysts see 6.00 % EPS growth. The stock increased 1.28% or $1.34 during the last trading session, reaching $106.1. About 469,286 shares traded or 32.76% up from the average. STERIS plc (NYSE:STE) has risen 29.66% since October 14, 2017 and is uptrending. It has outperformed by 14.04% the S&P500.

STERIS plc (NYSE:STE) Ratings Coverage

Among 2 analysts covering STERIS (NYSE:STE), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. STERIS had 2 analyst reports since August 9, 2018 according to SRatingsIntel. JMP Securities maintained STERIS plc (NYSE:STE) on Thursday, August 9 with “Market Outperform” rating. KeyBanc Capital Markets maintained the shares of STE in report on Thursday, August 9 with “Overweight” rating.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide. The company has market cap of $8.98 billion. The company??s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It has a 30.06 P/E ratio. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

STERIS plc (NYSE:STE) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.